Biotechnology & Healthcare
Our research reports are best viewed with with the most recent version of Adobe Acrobat Reader. Download a FREE copy here.
|
Audiotech Healthcare Corporation Audiotech operates in the highly-fragmented hearing healthcare industry in North America. Audiotech operates and manages a total of 14 hearing clinics in British Columbia, Alberta, and Idaho. Their goal is to establish a geographically diverse base of hearing clinics throughout North America upon completing its consolidation of clinics in the Pacific Northwest. |
|
02/07/2007 |
Bottom Lines Improves by 29.6% Despite Drop in Revenues; Final
Report (11 pages) |
Subscribers Only |
09/07/2006 |
Better Q3 Offsets Weak Q1 Revenues (10 pages) |
Subscribers Only |
06/02/2006 |
Q2 Inline With Expectations; Margins Exceed (16 pages) |
Subscribers Only |
03/08/2006 |
Initiating Coverage (16 pages) |
Subscribers Only |
|
Chemokine Therapeutics Corp. Founded on July 15, 1998, Chemokine Therapeutics (CTI) is an early stage biotechnology company specifically focused on developing protein-based drugs that belong to a class of cytokines known as chemokines. CTI is located in Vancouver, British Columbia, on the University of British Columbia Campus. |
|
08/21/2008 |
Reinitiating; Moving Forward With Phase II Trials of CTCE-9908 (21 pages) |
Subscribers Only |
04/07/2006 |
2005 Events on Track;
Final Report (8 pages) |
|
11/21/2005 |
Q3 Exciting Opportunities Ahead (9 pages) |
|
09/16/2005 |
Positive Developments Continue (3 Pages) |
|
08/19/2005 |
Q2 Continuing Positive Developments (7 Pages) |
|
06/24/2005 |
Initiating Coverage (30 Pages) |
The Jenex Corporation The Jenex Corporation (JEN) is a medical device research and development company focused on thermal therapy technology. The first product developed from this technology, Therapik, has an approved claim to stop the pain, itch and inflammation caused by insect bites. JEN will soon begin marketing their second product based on the technology, with the approved claim that the device prevents Herpes Labialis (cold sores). |
|
05/10/2004 |
Issuing Rating (17 pages) |
Resverlogix Corp. Resverlogix is a biotechnology company focused on the two largest drug markets - cancer and cholesterol. Its unique technology is focused on increasing HDL's (good cholesterol) as opposed to the more common focus of lowering LDL's (bad cholesterol). |
|
05/08/2004 |
Dropping Coverage (2 Pages) |
|
04/28/2004 |
Q3 and Update on Recent Events (5 Pages) |
|
03/17/2004 |
Initiating Coverage (16 Pages) |
Skinvisible Inc. Skinvisible, Inc. is a research and development company that has formulated and patented innovative polymer delivery technology and compositions for topical skin applications. Its primary objective and focus is to license its patented polymer delivery technology (Invisicare®) and sell its trademarked polymer delivery vehicles and formulated products to established dermatological, medical, cosmetic, cosmeceutical and skincare brand manufacturers. |
|
07/21/2008 |
Licensed three key acne products (10 pages) |
Subscribers Only |
02/25/2008 |
Initiating Coverage - Unique & attractive drug delivery system;
broad applications (25 pages) |
Subscribers Only |